|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR B AND T-CELL SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR HLA CLASS II DETERMINANTS
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR LYMPHOCYTE SUBTYPING
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|
|
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
|
EU IVDD
|
Eu Ivd General
|
On Market
|
0
|